Previous close | 11.90 |
Open | 9.70 |
Bid | 8.90 |
Ask | 9.40 |
Strike | 10.00 |
Expiry date | 2024-01-19 |
Day's range | 9.70 - 9.70 |
Contract range | N/A |
Volume | |
Open interest | 812 |
Shares of medical-imaging start-up company Nano-X Imaging (NASDAQ: NNOX), also known as Nanox, skyrocketed 191.2% in May, according to data provided by S&P Global Market Intelligence. Nanox intends to disrupt the X-ray market with its proprietary imaging technology. Nanox also wants to install machines at little or no cost to medical professionals, charging only a per-use fee.
Shares of Nano-X Imaging (NASDAQ: NNOX) are up more than 135% to start the year after the company got approval in April from the Food and Drug Administration (FDA) for its Nanox.ARC system. It may be too late to benefit from the stock's rise, but GE HealthCare Technologies (NASDAQ: GEHC) and Lantheus Holdings (NASDAQ: LNTH) are also involved with medical imaging and are less risky plays. The company showed improved revenue in the first quarter, but it is still losing money.
It could take years before Nano-X proves there's strong demand for its devices, and even longer to reach profitability.
When a stock breaks out above the 20-day simple moving average, good things could be on the horizon. How should investors react?
Shares of Nano-X Imaging (NASDAQ: NNOX) were up 10% Wednesday morning, a day after the stock fell below $17 for the first time since May 18. The healthcare company specializes in medical imaging equipment and systems and its shares are up more than 88% so far this year. Nano-X had been surging ever since the company announced on May 1 that it had received clearance from the Food and Drug Administration (FDA) to market Nanox.ARC, including the Nanox.CLOUD, its accompanying cloud-based infrastructure, as a stationary X-ray system on adults.
Investors looking for growth stocks that can make dramatic moves in a short time should look more closely at healthcare. The phase 2 trial tried four dosage strengths, and even the lowest dose led to liver-fat reduction of 30% or better for a majority of patients.
Shares of Nano-X Imaging (NASDAQ: NNOX), also known as Nanox, popped off more gains on Monday after the medical imaging device company reported financial results for the first quarter of 2023. As of 3:40 p.m. ET, Nanox stock was up 11%. Nanox is a very early stage company.
Earlier today, Nano-X Imaging Limited released financial results for the quarter ended March 31, 2023. Erez Meltzer, chief executive officer; and Ran Daniel, chief financial officer, will host this morning's call.
Reports progress towards global supply chain development Ended the first quarter of 2023 with cash, cash equivalents, restricted cash and marketable securities of $91.0 million Management to host conference call and webcast Monday, May 22, 2023 at 8:30 AM ET NEVE ILAN, Israel, May 22, 2023 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ: NNOX) (“Nanox” or the “Company”), an innovative medical imaging technology company, today announced results for the first quarter ended March 31, 2023 and provid
NEVE ILAN, Israel, May 17, 2023 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ("Nanox" or the "Company," Nasdaq: NNOX) will report its financial results for the first quarter ended March 31, 2023 before market on Monday, May 22, 2023. Erez Meltzer, Chief Executive Officer, and Ran Daniel, Chief Financial Officer, will host a conference call to review these results and provide a business update beginning at 8:30 a.m. ET. Interested parties may register for the conference call using the following link: N
Shares of start-up medical-imaging technology company Nano-X Imaging (NASDAQ: NNOX), or simply Nanox, jumped again on Thursday after it was announced that a major healthcare company increased its investment in the company. As of 3:40 p.m. ET, Nanox stock was up a whopping 17% for today's session and is now up more than 200% in May alone. Johnson & Johnson (NYSE: JNJ) is a behemoth in the healthcare space and, as it turns out, it's an investor in Nanox stock.
With the business potentially at an important milestone, we thought we'd take a closer look at Nano-X Imaging Ltd.'s...
The medical technology company has a new product with exciting potential -- but whether that will translate into profitable sales is less clear.
They don't always portend disaster, but you can avoid creating a disaster by knowing what to watch for.
Well, Nano-X Imaging's (NASDAQ: NNOX) stock is soaring at the moment, with its shares blasting off by 165% in the last 30 days. Here's what you need to know about Nano-X Imaging before considering whether to buy it. To make its product even more accessible to that market, the company is also pioneering a novel business model in which it only charges customers for the scans they run, rather than for the capital cost of the X-ray equipment.
Nano-X Imaging Ltd. (NNOX) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
Shares of medical technology company Nano-X Imaging (NASDAQ: NNOX), also known as Nanox, skyrocketed on Monday after the company received clearance from the Food and Drug Administration (FDA) for its flagship medical device. As of 10:30 a.m. ET, Nanox stock was up by a whopping 60%. Nanox intends to disrupt the world of X-ray technology with a medical imaging device that it says provides 3D digital images for a fraction of the cost of previously available technologies.
Nanox.ARC Image of the Nanox ARC Nanox.ARC Image of the Nanox ARC Nanox.ARC presents high powered digital X-ray tubes for 3D tomosynthesis imagingNanox.ARC could help expand the availability of medical imaging NEVE ILAN, Israel, May 01, 2023 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ("Nanox" or the "Company," Nasdaq: NNOX), an innovative medical imaging technology company, today announced that it has received a 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the multi-so
NEVE ILAN, Israel, May 01, 2023 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ("Nanox" or the "Company," Nasdaq: NNOX), an innovative medical imaging technology company, today announced that it has filed its annual report on Form 20-F for the fiscal year ended December 31, 2022 with the U.S. Securities and Exchange Commission (“SEC”) on May 1, 2023. The annual report on Form 20-F, which contains the Company’s audited consolidated financial statements, can be accessed on the SEC’s website at www.sec.gov
Nano-X Imaging (NASDAQ: NNOX) stock may be down 13% so far this year, but some see a much brighter future for the maker of digital x-ray equipment. Wall Street analysts are estimating that the stock will surge by an incredible 358% this year. It's special because it uses a digital x-ray source that's allegedly cheaper to use, less expensive to maintain, smaller, and easier to use than traditional analog ray sources.
It's easy to match the overall market return by buying an index fund. While individual stocks can be big winners...
Partnership with Ferrum Health offers unprecedented data security and an integrated AI platform to streamline health systems’ adoption of AI technology, such as Nanox’s Bone solution (HealthOST) and cardiac solution (HealthCCSng)NEVE ILAN, Israel, March 22, 2023 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ("Nanox" or the "Company," Nasdaq: NNOX), an innovative medical imaging technology company, today announced that that its deep-learning medical imaging analytics subsidiary, Nanox.AI, has entered in
Earlier today, Nano-X Imaging Limited released its financial results for the quarter ended December 31, 2022. Erez Meltzer, chief executive officer, and Ran Daniel, chief financial officer, will host this morning's call.
Reports progress towards global supply chain development Ended the fourth quarter of 2022 with cash, cash equivalents and marketable securities of $102.9 million Management to host conference call and webcast Thursday, March 9, 2023 at 8:30 AM ET NEVE ILAN, Israel, March 09, 2023 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ: NNOX) (“Nanox” or the “Company”), an innovative medical imaging technology company, today announced results for the fourth quarter ended December 31, 2022 and provided a b
NEVE ILAN, Israel, February 23, 2023--Nanox to Report Fourth Quarter 2022 Financial Results on March 9, 2023